EUR/USD to test 1.17 as the EU struggles to reinvigorate vaccine rollout – Westpac
|European Central Bank’s updated projections should reflect underperformance from slow distribution of Recovery Funds and covid vaccines. Thus, the EUR/USD pair may test 1.17-1.22 range support, economists at Westpac report.
Key quotes
“The European Union economy is likely to be constrained until well into H2 21 while economies such as the UK and US, with more successful vaccine rollouts and slowing new cases will outpace the EU. The ECB’s updated economic projections may well highlight the impact with only a minor uplift to regional growth compared to uplifts in other major economies.”
“ECB is likely to underscore its commitment to support the recovery and be flexible with its PEPP to avoid spread widening and excessive yield rises but is not likely to alter its policies otherwise.”
“The region’s underperformance in vaccine rollouts and consequent recovery underperformance is likely to weigh on EUR/USD which may now struggle within a lower 1.17-1.22 range through March.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.